Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.05 USD | -0.05% | -1.30% | -2.04% |
Apr. 29 | North American Morning Briefing : Investors Brace -2- | DJ |
Mar. 25 | Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.04% | 954M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Insider Buy: Cassava Sciences